Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp RVXCF


Primary Symbol: T.RVX

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Aug 24, 2022 8:42pm
222 Views
Post# 34918630

RE:Type C Meeting

RE:Type C Meeting,,see ,,the senior excects at RVX are possibly on apabetalone,,,,however,,,since these people dont understand the MOA of apabetalone they very likely are experiencing the opposite outcome than anticipated with ncreased onset of dementia,,they cant remember if they had a meeting or not,,,,,,,,oops,,,was that material??,,,,must have been a slip on my part,,,,aaccchhhh,,,,the disrespect shown to existing retail shareholders is also possibly unprecedented. But we will blame that on their own medicine combined with their management history of failure after failure,,,lmao!!!,,who knows,,and really who cares,,you cant believe anything out of this company,,,IR included,,,nothing will happen or change until upper management is removed from their respective positions,,,especially our CEO,,its just a fact of life imo.
<< Previous
Bullboard Posts
Next >>